BIO$372.183.18%-12.22
Bio Rad Laboratories Inc (BIO)
Date: 2026-10-30 16:00O: 381.09H: 384.00L: 368.45C: 372.18Vol: 183.1k
Bio Rad Laboratories Inc stock is traded at $372.18, with a volume of 183,084. It is down -3.18% in the last 24 hours and down -1.46% over the past month. Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Previous Close:
$384.40
Open:
$381.09
24h Volume:
183,084
Relative Volume:
0.80
Market Cap:
$9.95B
Revenue:
$2.59B
Net Income/Loss:
$168.80M
P/E Ratio:
61.27
EPS:
$6.07
Net Cash Flow:
$357.20M
1W Performance:
+0.60%
1M Performance:
-1.46%
6M Performance:
+32.86%
1Y Performance:
+22.18%
1-Day Range:
$368.45$384.00
1-Week Range:
$368.45$390.16
52-Week Range:
$236.73$396.23
Bio Rad Laboratories Inc Stock (BIO) Company Profile
Name
Bio Rad Laboratories IncSector
HealthcareIndustry
Medical DevicesPhone
(510) 724-7000Address
1000 ALFRED NOBEL DRIVE, HERCULES, USACompare BIO vs ABT, MDT, SYK, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BIO Bio Rad Laboratories Inc | $372.18 | $9.95B | $2.59B | $168.80M | $357.20M | $6.07 |
 ABT Abbott Laboratories | $106.20 | $183.77B | $46.59B | $5.41B | $7.38B | $3.09 |
 MDT Medtronic Plc | $96.54 | $123.49B | $36.36B | $4.84B | $5.43B | $3.73 |
 SYK Stryker Corp | $291.86 | $111.95B | $25.27B | $3.34B | $4.57B | $8.63 |
 BSX Boston Scientific Corp | $41.98 | $60.84B | $20.62B | $3.56B | $3.48B | $2.38 |
 EW Edwards Lifesciences Corp | $92.01 | $53.03B | $6.30B | $1.07B | $1.09B | $1.84 |
Bio Rad Laboratories Inc Stock (BIO) Upgrades & Downgrades
Bio Rad Laboratories Inc Stock (BIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
Bio Rad Laboratories Inc Stock (BIO) Insider Trading
- EVRAN SEDATOct 20 '26EVP, Global Supply Chain
- Transaction
- Option Exercise
- Cost
- $0.00
- #Shares
- 1,044
- Value ($)
- 0
- #Shares Total
- 4,647
- ENLOE COURTNEY CSep 06 '26EVP, General Counsel & Sec
- Transaction
- Option Exercise
- Cost
- $0.00
- #Shares
- 768
- Value ($)
- 0
- #Shares Total
- 1,957
- ENGELHARDT EVA ANETTESep 06 '26EVP, President, CDG
- Transaction
- Option Exercise
- Cost
- $0.00
- #Shares
- 1,152
- Value ($)
- 0
- #Shares Total
- 2,313
- Lakkaraju Roop KalyanSep 06 '26EVP, Chief Financial Officer
- Transaction
- Option Exercise
- Cost
- $0.00
- #Shares
- 1,536
- Value ($)
- 0
- #Shares Total
- 4,933
- Allison SchwartzSep 06 '26Director
- Transaction
- Option Exercise
- Cost
- $0.00
- #Shares
- 92
- Value ($)
- 0
- #Shares Total
- 1,768
- SCHWARTZ NORMAN DSep 06 '26Chairman & CEO
- Transaction
- Option Exercise
- Cost
- $0.00
- #Shares
- 3,455
- Value ($)
- 0
- #Shares Total
- 450,873
- EVRAN SEDATSep 06 '26EVP, Global Supply Chain
- Transaction
- Option Exercise
- Cost
- $0.00
- #Shares
- 864
- Value ($)
- 0
- #Shares Total
- 3,880
- BARRY JAMESSep 06 '26EVP, President, LSG
- Transaction
- Option Exercise
- Cost
- $0.00
- #Shares
- 1,056
- Value ($)
- 0
- #Shares Total
- 2,495
- Lakkaraju Roop KalyanSep 05 '26EVP, Chief Financial Officer
- Transaction
- Option Exercise
- Cost
- $0.00
- #Shares
- 1,370
- Value ($)
- 0
- #Shares Total
- 3,956
- SCHWARTZ NORMAN DSep 05 '26Chairman & CEO
- Transaction
- Option Exercise
- Cost
- $0.00
- #Shares
- 4,109
- Value ($)
- 0
- #Shares Total
- 450,294
